These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33176994)
1. Antibiotics for hospitalized children with community-acquired pneumonia in Japan: Analysis based on Japanese national database. Yahaba M; Yamagishi K; Yamazaki S; Takayanagi S; Kawasaki Y; Taniguchi T; Ishiwada N; Igari H J Infect Chemother; 2021 Mar; 27(3):461-465. PubMed ID: 33176994 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. Williams DJ; Edwards KM; Self WH; Zhu Y; Arnold SR; McCullers JA; Ampofo K; Pavia AT; Anderson EJ; Hicks LA; Bramley AM; Jain S; Grijalva CG JAMA Pediatr; 2017 Dec; 171(12):1184-1191. PubMed ID: 29084336 [TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738 [TBL] [Abstract][Full Text] [Related]
4. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia. Weiss K; Tillotson GS Chest; 2005 Aug; 128(2):940-6. PubMed ID: 16100190 [TBL] [Abstract][Full Text] [Related]
5. Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study. Yoon YK; Kim EJ; Chun BC; Eom JS; Park DW; Sohn JW; Kim MJ Respirology; 2012 Jan; 17(1):172-9. PubMed ID: 21995414 [TBL] [Abstract][Full Text] [Related]
6. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review. Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448 [TBL] [Abstract][Full Text] [Related]
7. Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study. Di Pietro P; Della Casa Alberighi O; Silvestri M; Tosca MA; Ruocco A; Conforti G; Rossi GA; Castagnola E; Merlano MC; Zappettini S; Renna S; Ital J Pediatr; 2017 Dec; 43(1):113. PubMed ID: 29273072 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy. Breuer O; Blich O; Cohen-Cymberknoh M; Averbuch D; Kharasch S; Shoseyov D; Kerem E Pediatr Pulmonol; 2015 May; 50(5):495-502. PubMed ID: 25652187 [TBL] [Abstract][Full Text] [Related]
9. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy. van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India. Kotwani A; Kumar S; Swain PK; Suri JC; Gaur SN Indian J Pharmacol; 2015; 47(4):375-82. PubMed ID: 26288468 [TBL] [Abstract][Full Text] [Related]
11. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database. Lee MG; Lee SH; Chang SS; Chan YL; Pang L; Hsu SM; Lee CC Medicine (Baltimore); 2015 Sep; 94(39):e1662. PubMed ID: 26426664 [TBL] [Abstract][Full Text] [Related]
12. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018. Kimura T; Ito M; Onozawa S J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180 [TBL] [Abstract][Full Text] [Related]
13. Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia. Cohen JF; Leis A; Lecarpentier T; Raymond J; Gendrel D; Chalumeau M PLoS One; 2012; 7(5):e36927. PubMed ID: 22615848 [TBL] [Abstract][Full Text] [Related]
14. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173 [TBL] [Abstract][Full Text] [Related]
15. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Peyrani P; Wiemken TL; Metersky ML; Arnold FW; Mattingly WA; Feldman C; Cavallazzi R; Fernandez-Botran R; Bordon J; Ramirez JA Infect Dis (Lond); 2018 Jan; 50(1):13-20. PubMed ID: 28699429 [TBL] [Abstract][Full Text] [Related]
16. [Guidelines for treatment of pneumonia in intensive care units]. Emmi V Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748 [TBL] [Abstract][Full Text] [Related]
17. Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia. Ambroggio L; Test M; Metlay JP; Graf TR; Blosky MA; Macaluso M; Shah SS Pediatr Pulmonol; 2016 May; 51(5):541-8. PubMed ID: 26367389 [TBL] [Abstract][Full Text] [Related]
18. Antibiotics prescriptions for pneumonia analyzed by claim information in Japan. Yamazaki S; Yamagishi K; Murata S; Yokoyama I; Yahaba M; Takayanagi S; Kawasaki Y; Taniguchi T; Ishii I; Igari H Int J Clin Pharmacol Ther; 2021 Apr; 59(4):289-297. PubMed ID: 33287955 [TBL] [Abstract][Full Text] [Related]
19. Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia. Tapısız A; Özdemir H; Çiftçi E; Belet N; Ince E; Doğru Ü J Infect Chemother; 2011 Aug; 17(4):504-9. PubMed ID: 21258955 [TBL] [Abstract][Full Text] [Related]
20. Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis. Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Yasunaga H J Infect Chemother; 2019 Dec; 25(12):1012-1018. PubMed ID: 31227381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]